Total Synthesis of Aloin by Regioselective Diels–Alder Reactions Connecting Two 3-Silylbenzynes and a 2-Stannylfuran
Synlett · 17.06.2025 · 36 (10) · 1413-1417
DOI: 10.1055/a-2542-3481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synlett, erschienen am 17.06.2025. Verfasst von Shuji Akai und 9 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Science and Technology Agency.
Abstract (Originalsprache)
The first synthesis of aloin, a natural anthrone C-glycoside, was achieved through two sequential Diels–Alder (DA) reactions connecting two 3-silylbenzynes and a 2-stannylfuran. The silyl and stannyl substituents contributed to the regioselectivity of the two DA reactions and the 9,10-ether cleavage of the DA adduct. Subsequent conversion of the silyl groups into hydroxy groups and a C10-glycosylation completed the synthesis of aloin.
Förderung
- Japan Agency for Medical Research and Development
- Japan Science and Technology Agency
Zitieren
APA
Akai, S., Moriyama, S., Emi, Y., Nosaki, T., Morikawa, Y., Shigeta, T., Takagi, A., Egi, M., Ikawa, T., & Sawama, Y. (2025). Total Synthesis of Aloin by Regioselective Diels–Alder Reactions Connecting Two 3-Silylbenzynes and a 2-Stannylfuran. Synlett, 36(10), 1413-1417. https://doi.org/10.1055/a-2542-3481
Vancouver
Akai S, Moriyama S, Emi Y, Nosaki T, Morikawa Y, Shigeta T, et al. Total Synthesis of Aloin by Regioselective Diels–Alder Reactions Connecting Two 3-Silylbenzynes and a 2-Stannylfuran. Synlett. 2025;36(10):1413-1417. doi:10.1055/a-2542-3481
BibTeX
@article{Akai2025,
author = {Akai, Shuji and Moriyama, Shogo and Emi, Yuto and Nosaki, Toshifumi and Morikawa, Yuki and Shigeta, Takashi and Takagi, Akira and Egi, Masahiro and Ikawa, Takashi and Sawama, Yoshinari},
title = {Total Synthesis of Aloin by Regioselective Diels–Alder Reactions Connecting Two 3-Silylbenzynes and a 2-Stannylfuran},
journal = {Synlett},
year = {2025},
volume = {36},
number = {10},
pages = {1413--1417},
doi = {10.1055/a-2542-3481}
}
EUVIMED